Skip to main content
Clinical Trials/NCT02553421
NCT02553421
Completed
Not Applicable

Optical Detection of Intravenous Infiltration:A Pilot Study

ivWatch, LLC1 site in 1 country243 target enrollmentAugust 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infiltration of Peripheral IV Therapy
Sponsor
ivWatch, LLC
Enrollment
243
Locations
1
Primary Endpoint
Time Infiltration Detected by Nurse
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This study will examine the use of the ivWatch Model 400 to monitor PIV sites in pediatric patients. Half the participants will be monitored by the device without infiltration notifications and the other half will be monitored by the device with infiltration notifications enabled.

Registry
clinicaltrials.gov
Start Date
August 2015
End Date
July 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Signed consent and/or assent
  • Newborn to 17 years of age
  • Weight \> 2.5 kg

Exclusion Criteria

  • Severe skin integrity issues such as severe eczema, burns, epidermolysis bullosa, rash, hives
  • Severe scarring of tissue (excessive IV use)
  • Tattoo in area of PIV site
  • IV site located in antecubital fossa

Outcomes

Primary Outcomes

Time Infiltration Detected by Nurse

Time Frame: Participants will be followed for the duration of intravenous therapy, an expected duration of up to 1 week

The difference in time to detection between the clinician and the ivWatch device is measured from the non-alarming group. This measurement reveals how much earlier the infiltration could have been detected by the ivWatch device compared to the clinician assessments. This metric is measured using the patients in the non-alarming group since an infiltration notification by the ivWatch device could bias the clinician's diagnosis.

Infiltration Sensitivity

Time Frame: Participants will be followed for the duration of intravenous therapy, an expected duration of up to 1 week

The infiltration sensitivity is defined as the percentage of the clinician-confirmed infiltrations that are detected by the ivWatch device before the clinician's diagnosis. This metric is measured and reported separately for non-alarming and alarming groups, since an infiltration notification by the ivWatch device could bias the clinician's diagnosis.

Notification Rate of ivWatch Device

Time Frame: Participants will be followed for the duration of intravenous therapy, an expected duration of up to 1 week

The notification rate is defined as the number of ivWatch device infiltration notifications issued in a certain amount of time, typically reported in units of notifications per day. The notification rate is the number of notifications per day, excluding cases with clinician confirmed infiltrations. This metric is measured using the subjects in the alarming group since the number of notifications could potentially depend on how quickly nurses reset the device.

Study Sites (1)

Loading locations...

Similar Trials